Skip to main content
. 2021 Aug 10;13(16):4018. doi: 10.3390/cancers13164018

Table 1.

Descriptive Statistics.

n (Total = 2671) %
Gender
Male 1465 54.8
Female 1206 45.2
Age
<55 589 22.1
55–64 696 26.1
65–74 810 30.3
≥75 576 21.6
Setting
Inpatients 1015 36.0
Outpatients/DH 1250 46.8
Hospice/Home palliative care 406 15.2
Primary Tumor
Lung 665 24.9
Gastrointestinal 470 17.6
Breast 278 10.4
Pancreas 237 8.9
Uro-gynecological 401 15.0
Other 620 23.2
n° of BTcP
1 791 29.6
2 1082 40.5
3 621 23.2
4 177 6.6
Intensity of BTcP
5 118 4.4
6 394 14.8
7 840 31.4
8 849 31.8
9 277 10.4
10 193 7.2
Type of BtcP Pain
Nociceptive 672 25.2
Neurophatic 214 8.0
Both types 1785 66.8
Onset
≤10 min 1806 67.6
>10 min 865 32.4
BTcP therapy
None 366 13.8
ROOs ^ 1302 48.7
Morphine ° 545 20.4
Other 458 17.1

Abbreviations: RT—radiotherapy; DH—day hospital; ROOs—rapid-onset opioids. Legend: ^ ROOs include: OTFC—oral transmucosal fentanyl citrate; FBT—fentanyl buccal tablet; FBST—sublingual fentanyl; FPNS—fentanyl pectin nasal spray. ° Morphine given by the oral, subcutaneous, intramuscular, or intravenous route.